Genome Mining of Endophytic Streptomyces wadayamensis Reveals High Antibiotic Production Capability

AUTOR(ES)

Angolini, Célio F. F., Gonçalves, Ana B., Sigrist, Renata, Paulo, Bruno S., Samborskyy, Markiyan, Cruz, Pedro L. R., Vivian, Adriana F., Schmidt, Eduardo M., Eberlin, Marcos N., Araújo, Welington L., Oliveira, Luciana G. de

FONTE

J. Braz. Chem. Soc.

DATA DE PUBLICAÇÃO

2016-08

RESUMO

The actinobacteria Streptomyces wadayamensis A23, an endophitic strain, was recently sequenced and previous work showed qualitatively that the strain inhibits the growth of some pathogens. Herein we report the genome analysis of S. wadayamensis which reveals several antibiotic biosynthetic pathways. Using mass spectrometry, we were able to identify desferoxamines, several antimycins and candicidin, as predicted. Additionally, it was possible to confirm that the biosynthetic machinery of the strain when compared to identified known metabolites is far underestimated. As suggested by biochemical qualitative tests, genome encoded information reveals that the strain A23 has high capability to produce antibiotics.

Documentos Relacionados

• The Production of an Antifungal Antibiotic by Streptomyces griseus
• Multigene families for anthracycline antibiotic production in Streptomyces peucetius.
• Production of polypeptide antibiotic from Streptomyces parvulus and its antibacterial activity
• Production, purification, and characterization of chandramycin, a polypeptide antibiotic from Streptomyces lydicus.
• Engineering of Primary Carbon Metabolism for Improved Antibiotic Production in Streptomyces lividans†